Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Mara ten Kate(Christian-Albrechts-Universität zu Kiel), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Gaël Chételat(Inserm), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Philip Scheltens(Amsterdam University Medical Centers), Pieter Jelle Visser(Karolinska Institutet), Craig Ritchie(Western General Hospital), José Luís Molinuevo(Pasqual Maragall Foundation), Michael Ewers(German Center for Neurodegenerative Diseases), Bart N.M. van Berckel(Amsterdam Neuroscience), Sven Haller(Ulsan College), Adam Waldman(Royal Society of Edinburgh), Adriaan A. Lammertsma(University Medical Center Groningen), Juan Domingo Gispert(Lund University), Mark E. Schmidt(Janssen (Belgium)), Adam J. Schwarz(Eli Lilly (United States)), David Hill(Guy's Hospital), Christopher Foley(Baylor College of Medicine), Silvia Ingala(University of Geneva), Michael C. Irizarry(Eisai (United States)), Joanna M. Wardlaw(University of Edinburgh)
Cited by 60
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Nonrigid registration using free-form deformations: application to breast MR images
|IEEE Transactions on Medical Imaging|1999|5.3k